Literature DB >> 27917095

Diagnosis, Treatment, and Monitoring of Patients With Primary Biliary Cholangitis.

Fred Poordad1.   

Abstract

Entities:  

Year:  2016        PMID： 27917095      PMCID： PMC5114515     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  5 in total

Review 1.  Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach.

Authors:  Hani S Mousa; Marco Carbone; Federica Malinverno; Vincenzo Ronca; M Eric Gershwin; Pietro Invernizzi
Journal:  Autoimmun Rev       Date:  2016-07-06       Impact factor: 9.754

Review 2.  Primary biliary cirrhosis.

Authors:  Elizabeth J Carey; Ahmad H Ali; Keith D Lindor
Journal:  Lancet       Date:  2015-09-11       Impact factor: 79.321

3.  Fatigue in Primary Biliary Cirrhosis: Prevalence, Pathogenesis and Management.

Authors:  Laura Jopson; David E J Jones
Journal:  Dig Dis       Date:  2015-12-07       Impact factor: 2.404

4.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study.

Authors:  Willem J Lammers; Henk R van Buuren; Gideon M Hirschfield; Harry L A Janssen; Pietro Invernizzi; Andrew L Mason; Cyriel Y Ponsioen; Annarosa Floreani; Christophe Corpechot; Marlyn J Mayo; Pier M Battezzati; Albert Parés; Frederik Nevens; Andrew K Burroughs; Kris V Kowdley; Palak J Trivedi; Teru Kumagi; Angela Cheung; Ana Lleo; Mohamad H Imam; Kirsten Boonstra; Nora Cazzagon; Irene Franceschet; Raoul Poupon; Llorenç Caballeria; Giulia Pieri; Pushpjeet S Kanwar; Keith D Lindor; Bettina E Hansen
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682

5.  Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Authors:  Ulrich Beuers; M Eric Gershwin; Robert G Gish; Pietro Invernizzi; David E J Jones; Keith Lindor; Xiong Ma; Ian R Mackay; Albert Parés; Atsushi Tanaka; John M Vierling; Raoul Poupon
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.